Wei Chang Zhou
Director/Board Member at WUXI BIOLOGICS (CAYMAN) INC.
Net worth: 714 532 $ as of 2024-06-29
Wei Chang Zhou active positions
| Companies | Position | Start | End |
|---|---|---|---|
| WUXI BIOLOGICS (CAYMAN) INC. | Director/Board Member | 2016-04-30 | - |
| Chief Tech/Sci/R&D Officer | 2016-10-31 | 2024-03-30 | |
| WUXI XDC CAYMAN INC. | Director/Board Member | 2020-11-30 | - |
Career history of Wei Chang Zhou
Former positions of Wei Chang Zhou
| Companies | Position | Start | End |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Director/Board Member | 2008-02-29 | 2012-11-30 |
| PDL BIOPHARMA, INC. | Director/Board Member | 2002-09-30 | 2008-01-31 |
| MERCK & CO., INC. | Corporate Officer/Principal | 1994-04-30 | 2002-09-30 |
Training of Wei Chang Zhou
| Jiangxi University of Science & Technology | Undergraduate Degree |
| University of Hannover | Doctorate Degree |
Statistics
International
| China | 4 |
| United States | 4 |
| Germany | 2 |
Operational
| Director/Board Member | 4 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| WUXI XDC CAYMAN INC. | Commercial Services |
| Private companies | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
- Stock Market
- Insiders
- Wei Chang Zhou
- Experience
